1 | sclerosis | 2,781 |
2 | myeloma | 1,204 |
3 | nervosa | 678 |
4 | erythematosus | 578 |
5 | imputation | 566 |
6 | nephritis | 471 |
7 | epicondylitis | 164 |
8 | keratectomy | 90 |
9 | parapatellar | 52 |
10 | imputations | 42 |
11 | epicondylalgia | 33 |
12 | epicondylosis | 19 |
13 | fibroelastosis | 17 |
14 | suppurativa | 16 |
15 | cephalogram | 15 |
16 | canalolithiasis | 9 |
17 | mini-interview | 9 |
18 | plexi | 7 |
19 | asp1104his | 6 |
20 | sclerosis-related | 6 |
21 | attempter | 5 |
22 | errands | 5 |
23 | exostoses | 5 |
24 | heat-shocks | 5 |
25 | oppositions | 5 |
26 | sectionectomy | 5 |
27 | suppurativa/acne | 5 |
28 | asters | 4 |
29 | cbnp | 4 |
30 | erythematosis | 4 |
31 | reaction-monitoring | 4 |
32 | sclerosis-associated | 4 |
33 | subpial | 4 |
34 | 3-d-rois | 3 |
35 | pruritogens | 3 |
36 | shanks | 3 |
37 | tibio-femoral | 3 |
38 | antibioticsmore | 2 |
39 | canthopexy | 2 |
40 | carefully-selected | 2 |
41 | cystoliths | 2 |
42 | erythematodes | 2 |
43 | hypotension-related | 2 |
44 | impactors | 2 |
45 | kim® | 2 |
46 | mechanisms.3 | 2 |
47 | meyloma | 2 |
48 | nervosa-restricting | 2 |
49 | ring-enhancing | 2 |
50 | satranidazole | 2 |
51 | urti-related | 2 |
52 | z-plasties | 2 |
53 | '-oms | 1 |
54 | 'nutraceuticals | 1 |
55 | 0-5-year-olds | 1 |
56 | 4-rate-constant | 1 |
57 | 48/111 | 1 |
58 | alfredi | 1 |
59 | anaemia.with | 1 |
60 | anticoagulant-positive | 1 |
61 | athletica | 1 |
62 | audiences-from | 1 |
63 | autoantigen-binding | 1 |
64 | azithromax | 1 |
65 | bendings | 1 |
66 | borderlands | 1 |
67 | bp/pathway-specific | 1 |
68 | capusolorrhaphy | 1 |
69 | carborhodations | 1 |
70 | cephalography | 1 |
71 | chorangiomas | 1 |
72 | co-morbidities.a | 1 |
73 | commissuroplasties | 1 |
74 | crossover-periods/multiple | 1 |
75 | donnings | 1 |
76 | embolication | 1 |
77 | endothelial-myocyte | 1 |
78 | erythmatodes | 1 |
79 | erythmatosus | 1 |
80 | erythrematosus | 1 |
81 | ezythematosus | 1 |
82 | fg-rt-pcr | 1 |
83 | filtrations | 1 |
84 | gap-pcr | 1 |
85 | gas-standardization | 1 |
86 | gsk3-phosphorylation | 1 |
87 | hla-dr-genotypes | 1 |
88 | hypercaptation | 1 |
89 | hystologic | 1 |
90 | il-family | 1 |
91 | indicators-multiple | 1 |
92 | inflammatory-cytokines | 1 |
93 | inputs-driven | 1 |
94 | l50a | 1 |
95 | lanuginosa | 1 |
96 | leave/disability | 1 |
97 | levonogestrel | 1 |
98 | micro-abscesses | 1 |
99 | micro-fistulas | 1 |
100 | midface-zygoma | 1 |
101 | mini-interviews | 1 |
102 | myeloaplasia | 1 |
103 | myeloma-induced | 1 |
104 | myeloma/ | 1 |
105 | nervosa-are | 1 |
106 | nervosa-restrictive | 1 |
107 | neuropenia | 1 |
108 | neutophilic | 1 |
109 | nkr-5-3a | 1 |
110 | olivocochlear | 1 |
111 | osteoarthrits | 1 |
112 | outputation | 1 |
113 | palpetion | 1 |
114 | partially-refolded | 1 |
115 | pcr/rt-pcr | 1 |
116 | planimetry.twenty | 1 |
117 | polyexponential | 1 |
118 | post-antipyretic | 1 |
119 | pre-flaring | 1 |
120 | pre-frontal/cingulate | 1 |
121 | proofs-of-concept | 1 |
122 | re-deployments | 1 |
123 | recumbence | 1 |
124 | sclerosis-fatigue | 1 |
125 | sclerosis-specific | 1 |
126 | sclerosis-to | 1 |
127 | sclerosis.2 | 1 |
128 | sclerosis.we | 1 |
129 | seafarer | 1 |
130 | sectorectomy | 1 |
131 | semi-hdc | 1 |
132 | sensitivity-analyses | 1 |
133 | session-srp | 1 |
134 | settings-is | 1 |
135 | subescale | 1 |
136 | suppuritiva | 1 |
137 | suturectomies | 1 |
138 | t-epitopes | 1 |
139 | tethys | 1 |
140 | thoracenesis/biopsy | 1 |
141 | thump | 1 |
142 | tilt.position | 1 |
143 | tissue-/developmental | 1 |
144 | vaginourethrogram | 1 |
1 | '-oms | 1 |
2 | 'nutraceuticals | 1 |
3 | 0-5-year-olds | 1 |
4 | 3-d-rois | 3 |
5 | 4-rate-constant | 1 |
6 | 48/111 | 1 |
7 | alfredi | 1 |
8 | anaemia.with | 1 |
9 | antibioticsmore | 2 |
10 | anticoagulant-positive | 1 |
11 | asp1104his | 6 |
12 | asters | 4 |
13 | athletica | 1 |
14 | attempter | 5 |
15 | audiences-from | 1 |
16 | autoantigen-binding | 1 |
17 | azithromax | 1 |
18 | bendings | 1 |
19 | borderlands | 1 |
20 | bp/pathway-specific | 1 |
21 | canalolithiasis | 9 |
22 | canthopexy | 2 |
23 | capusolorrhaphy | 1 |
24 | carborhodations | 1 |
25 | carefully-selected | 2 |
26 | cbnp | 4 |
27 | cephalogram | 15 |
28 | cephalography | 1 |
29 | chorangiomas | 1 |
30 | co-morbidities.a | 1 |
31 | commissuroplasties | 1 |
32 | crossover-periods/multiple | 1 |
33 | cystoliths | 2 |
34 | donnings | 1 |
35 | embolication | 1 |
36 | endothelial-myocyte | 1 |
37 | epicondylalgia | 33 |
38 | epicondylitis | 164 |
39 | epicondylosis | 19 |
40 | errands | 5 |
41 | erythematodes | 2 |
42 | erythematosis | 4 |
43 | erythematosus | 578 |
44 | erythmatodes | 1 |
45 | erythmatosus | 1 |
46 | erythrematosus | 1 |
47 | exostoses | 5 |
48 | ezythematosus | 1 |
49 | fg-rt-pcr | 1 |
50 | fibroelastosis | 17 |
51 | filtrations | 1 |
52 | gap-pcr | 1 |
53 | gas-standardization | 1 |
54 | gsk3-phosphorylation | 1 |
55 | heat-shocks | 5 |
56 | hla-dr-genotypes | 1 |
57 | hypercaptation | 1 |
58 | hypotension-related | 2 |
59 | hystologic | 1 |
60 | il-family | 1 |
61 | impactors | 2 |
62 | imputation | 566 |
63 | imputations | 42 |
64 | indicators-multiple | 1 |
65 | inflammatory-cytokines | 1 |
66 | inputs-driven | 1 |
67 | keratectomy | 90 |
68 | kim® | 2 |
69 | l50a | 1 |
70 | lanuginosa | 1 |
71 | leave/disability | 1 |
72 | levonogestrel | 1 |
73 | mechanisms.3 | 2 |
74 | meyloma | 2 |
75 | micro-abscesses | 1 |
76 | micro-fistulas | 1 |
77 | midface-zygoma | 1 |
78 | mini-interview | 9 |
79 | mini-interviews | 1 |
80 | myeloaplasia | 1 |
81 | myeloma | 1,204 |
82 | myeloma-induced | 1 |
83 | myeloma/ | 1 |
84 | nephritis | 471 |
85 | nervosa | 678 |
86 | nervosa-are | 1 |
87 | nervosa-restricting | 2 |
88 | nervosa-restrictive | 1 |
89 | neuropenia | 1 |
90 | neutophilic | 1 |
91 | nkr-5-3a | 1 |
92 | olivocochlear | 1 |
93 | oppositions | 5 |
94 | osteoarthrits | 1 |
95 | outputation | 1 |
96 | palpetion | 1 |
97 | parapatellar | 52 |
98 | partially-refolded | 1 |
99 | pcr/rt-pcr | 1 |
100 | planimetry.twenty | 1 |
101 | plexi | 7 |
102 | polyexponential | 1 |
103 | post-antipyretic | 1 |
104 | pre-flaring | 1 |
105 | pre-frontal/cingulate | 1 |
106 | proofs-of-concept | 1 |
107 | pruritogens | 3 |
108 | re-deployments | 1 |
109 | reaction-monitoring | 4 |
110 | recumbence | 1 |
111 | ring-enhancing | 2 |
112 | satranidazole | 2 |
113 | sclerosis | 2,781 |
114 | sclerosis-associated | 4 |
115 | sclerosis-fatigue | 1 |
116 | sclerosis-related | 6 |
117 | sclerosis-specific | 1 |
118 | sclerosis-to | 1 |
119 | sclerosis.2 | 1 |
120 | sclerosis.we | 1 |
121 | seafarer | 1 |
122 | sectionectomy | 5 |
123 | sectorectomy | 1 |
124 | semi-hdc | 1 |
125 | sensitivity-analyses | 1 |
126 | session-srp | 1 |
127 | settings-is | 1 |
128 | shanks | 3 |
129 | subescale | 1 |
130 | subpial | 4 |
131 | suppurativa | 16 |
132 | suppurativa/acne | 5 |
133 | suppuritiva | 1 |
134 | suturectomies | 1 |
135 | t-epitopes | 1 |
136 | tethys | 1 |
137 | thoracenesis/biopsy | 1 |
138 | thump | 1 |
139 | tibio-femoral | 3 |
140 | tilt.position | 1 |
141 | tissue-/developmental | 1 |
142 | urti-related | 2 |
143 | vaginourethrogram | 1 |
144 | z-plasties | 2 |
1 | myeloma/ | 1 |
2 | 48/111 | 1 |
3 | sclerosis.2 | 1 |
4 | mechanisms.3 | 2 |
5 | co-morbidities.a | 1 |
6 | l50a | 1 |
7 | nkr-5-3a | 1 |
8 | athletica | 1 |
9 | epicondylalgia | 33 |
10 | neuropenia | 1 |
11 | myeloaplasia | 1 |
12 | midface-zygoma | 1 |
13 | myeloma | 1,204 |
14 | meyloma | 2 |
15 | lanuginosa | 1 |
16 | nervosa | 678 |
17 | suppurativa | 16 |
18 | suppuritiva | 1 |
19 | semi-hdc | 1 |
20 | sclerosis-specific | 1 |
21 | bp/pathway-specific | 1 |
22 | hystologic | 1 |
23 | neutophilic | 1 |
24 | post-antipyretic | 1 |
25 | myeloma-induced | 1 |
26 | partially-refolded | 1 |
27 | sclerosis-associated | 4 |
28 | urti-related | 2 |
29 | hypotension-related | 2 |
30 | sclerosis-related | 6 |
31 | carefully-selected | 2 |
32 | recumbence | 1 |
33 | subescale | 1 |
34 | satranidazole | 2 |
35 | indicators-multiple | 1 |
36 | crossover-periods/multiple | 1 |
37 | suppurativa/acne | 5 |
38 | nervosa-are | 1 |
39 | antibioticsmore | 2 |
40 | pre-frontal/cingulate | 1 |
41 | endothelial-myocyte | 1 |
42 | sclerosis-fatigue | 1 |
43 | nervosa-restrictive | 1 |
44 | anticoagulant-positive | 1 |
45 | sclerosis.we | 1 |
46 | ring-enhancing | 2 |
47 | autoantigen-binding | 1 |
48 | pre-flaring | 1 |
49 | reaction-monitoring | 4 |
50 | nervosa-restricting | 2 |
51 | anaemia.with | 1 |
52 | alfredi | 1 |
53 | plexi | 7 |
54 | subpial | 4 |
55 | polyexponential | 1 |
56 | tibio-femoral | 3 |
57 | tissue-/developmental | 1 |
58 | levonogestrel | 1 |
59 | cephalogram | 15 |
60 | vaginourethrogram | 1 |
61 | audiences-from | 1 |
62 | inputs-driven | 1 |
63 | embolication | 1 |
64 | gsk3-phosphorylation | 1 |
65 | hypercaptation | 1 |
66 | imputation | 566 |
67 | outputation | 1 |
68 | gas-standardization | 1 |
69 | palpetion | 1 |
70 | tilt.position | 1 |
71 | sclerosis-to | 1 |
72 | thump | 1 |
73 | cbnp | 4 |
74 | session-srp | 1 |
75 | olivocochlear | 1 |
76 | parapatellar | 52 |
77 | gap-pcr | 1 |
78 | fg-rt-pcr | 1 |
79 | pcr/rt-pcr | 1 |
80 | seafarer | 1 |
81 | attempter | 5 |
82 | micro-fistulas | 1 |
83 | chorangiomas | 1 |
84 | 0-5-year-olds | 1 |
85 | borderlands | 1 |
86 | errands | 5 |
87 | erythematodes | 2 |
88 | erythmatodes | 1 |
89 | suturectomies | 1 |
90 | z-plasties | 2 |
91 | commissuroplasties | 1 |
92 | inflammatory-cytokines | 1 |
93 | t-epitopes | 1 |
94 | hla-dr-genotypes | 1 |
95 | exostoses | 5 |
96 | micro-abscesses | 1 |
97 | sensitivity-analyses | 1 |
98 | bendings | 1 |
99 | donnings | 1 |
100 | cystoliths | 2 |
101 | settings-is | 1 |
102 | asp1104his | 6 |
103 | 3-d-rois | 3 |
104 | canalolithiasis | 9 |
105 | epicondylosis | 19 |
106 | sclerosis | 2,781 |
107 | erythematosis | 4 |
108 | fibroelastosis | 17 |
109 | epicondylitis | 164 |
110 | nephritis | 471 |
111 | heat-shocks | 5 |
112 | shanks | 3 |
113 | 'nutraceuticals | 1 |
114 | '-oms | 1 |
115 | pruritogens | 3 |
116 | carborhodations | 1 |
117 | filtrations | 1 |
118 | imputations | 42 |
119 | oppositions | 5 |
120 | asters | 4 |
121 | impactors | 2 |
122 | osteoarthrits | 1 |
123 | re-deployments | 1 |
124 | erythematosus | 578 |
125 | ezythematosus | 1 |
126 | erythrematosus | 1 |
127 | erythmatosus | 1 |
128 | mini-interviews | 1 |
129 | tethys | 1 |
130 | 4-rate-constant | 1 |
131 | proofs-of-concept | 1 |
132 | mini-interview | 9 |
133 | azithromax | 1 |
134 | capusolorrhaphy | 1 |
135 | cephalography | 1 |
136 | il-family | 1 |
137 | sectionectomy | 5 |
138 | sectorectomy | 1 |
139 | keratectomy | 90 |
140 | thoracenesis/biopsy | 1 |
141 | leave/disability | 1 |
142 | planimetry.twenty | 1 |
143 | canthopexy | 2 |
144 | kim® | 2 |